Skip to main content

Table 2 Simplified esophageal pressure–time product, respiratory variables, and hemodynamic variables during non-invasive ventilation and high-flow nasal cannula at different flow rates

From: Effects of high-flow nasal cannula and non-invasive ventilation on inspiratory effort in hypercapnic patients with chronic obstructive pulmonary disease: a preliminary study

Variables

NIV

HFNC-10

HFNC-20

HFNC-30

HFNC-40

HFNC-50

p

sPTPes per breath (cmH2O × s)

9 ± 4

11 ± 5

11 ± 6

10 ± 6

10 ± 5

10 ± 4

0.090

sPTPes per minute (cmH2O × s × min−1)

183 ± 84

220 ± 100

211 ± 90

187 ± 84*,**

189 ± 87

201 ± 86

< 0.001

RR (breaths/min)

25 [20–28]

24 [20–29]

23 [18–28]

21 [18–27]*

21 [18–27]*

21 [18–26]*

0.003

SpO2 (%)

96 ± 2

95 ± 3

96 ± 3*

97 ± 3*,**

97 ± 2*,**

98 ± 2*,**, γ

0.028

PtcCO2 (mmHg)

42 ± 7

41 ± 7

41 ± 8

41 ± 7

41 ± 7

41 ± 7

0.335

MAP (mmHg)

99 ± 22

94 ± 15

92 ± 9

91 ± 12

89 ± 12

91 ± 14

0.179

HR (beats/min)

96 ± 16

97 ± 15

94 ± 13

93 ± 14

94 ± 16

95 ± 17

0.174

Oxygen flow (L/min) or Set FiO2

4 [3–5]

0.35 [0.30–0.40]

0.35 [0.30–0.40]

0.35 [0.30–0.40]

0.35 [0.30–0.40]

0.35 [0.30–0.40]

  1. Continuous variables were presented as mean ± SD or median [interquartile range] and categorical variables were presented as absolute value (%)
  2. HFNC high-flow nasal cannula, HR heart rate, MAP mean arterial pressure, NIV non-invasive ventilation, sPTPes, simplified esophageal pressure–time product, PtcCO2, transcutaneous carbon dioxide pressure, RR respiratory rate, SpO2, oxygen saturation
  3. * Indicates p < 0.05 compared with HNFC-10, ** Indicates p < 0.05 compared with HFNC-20, γIndicates p < 0.05 compared with NIV